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Abstract
Turner syndrome (TS) is an interesting model for investigating the association between methylenetetrahydrofolate
reductase (MTHFR) gene polymorphisms and non-disjunction because of the high frequency of chromosomal
mosaicism among patients with this syndrome. We determined the frequencies of MTHFR 677C  T and 1298A 
C polymorphic mutations in 49 patients with TS and 200 control individuals. The frequency of the 677C  T allele
was 0.39 for patients and 0.29 for controls while that of the 1298A  C allele was 0.28 for patients and 0.25 for con-
trols. Genotype frequencies were shown to be different in patients and controls (2 = 12.143; p = 0.033), and this was
attributable to the higher frequency of the C677C  T /677C  T genotype among TS patients. In homozygotes, this
mutation might have an effect on somatic chromosome disjunction by decreasing MTHFR activity.
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Defects in folic acid metabolism because of muta-
tions in the 5,10-methylenetetrahydrofolate reductase
(MTHFR) gene have been considered as a possible cause of
chromosomal non-disjunction by hypomethylation (James
et al., 1999; Hobbs et al., 2000). The MTHFR gene is lo-
cated on the short arm of chromosome 1 (1p36.3) and has
11 exons (Goyette et al., 1994) which code for a cytosolic
flavoprotein that catalyzes the reduction of 5,10-methyl-
enetetrahydrofolate (5,10-methyleneTHF) to 5-methylte-
trahydrofolate (5-methylTHF), the predominant circulating
form of folic acid (Weisberg et al., 1998). One of the meta-
bolic products, S-adenosylmethionine (SAM), is a methyl
donor in various methylation reactions, including DNA and
protein methylation and phospholipid synthesis (Chiang et
al., 1996).
Frosst et al. (1995) identified a C to T substitution at
nucleotide 677 in the coding region of the MTHFR gene
converting an alanine to a valine residue in the gene product
and creating a new HinfI restriction site resulting in the
MTHFR 677C  T polymorphism and a reduction in en-
zyme activity which may lead to a decrease in the levels of
SAM, inhibition of methyltransferase and subsequent DNA
hypomethylation. The importance of the stable methylation
of pericentromeric DNA for chromosomal stabilization and
segregation has been supported both by clinical and experi-
mental data (reviewed by Hobbs et al., 2000). Therefore, in
homozygosis, the 677C  T mutation may be a contribut-
ing risk factor to somatic chromosomal non-disjunction.
James et al. (1999) studied the mothers of Down syn-
drome children and found a high frequency of mothers who
were heterozygous for the MTHFR 677C  T polymor-
phism, suggesting that this mutation might be a risk factor
for chromosome 21 non-disjunction. Hobbs et al. (2000)
further investigated this association and in addition studied
the methionine synthase reductase (MTRR) gene, also in-
volved in folate metabolism, and found not only that the
MTRR 66A  G polymorphism was independently associ-
ated with a 2.6 fold increase in the estimated risk for Down
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syndrome when mothers were homozygous for this gene
but that the presence of both the polymorphisms was asso-
ciated with a greater risk than was the presence of either
alone.
However, the association between the MTHFR
677C  T and MTRR 66A  G polymorphisms is still con-
troversial. In an extensive study, Hassold et al. (2001) de-
termined the frequencies of the MTHFR 677C  T poly-
morphism in mothers of 93 cases of sex chromosome
trisomy, 158 cases of chromosome 2, 7, 10, 13, 14, 15, 16
and 22 trisomy and 44 cases of trisomy 18 but detected sig-
nificant increase in the 677C  T polymorphism only in
mothers of trisomy 18 concepti. Even so, Chadefaux-Veke-
man et al. (2002) did not detect any significant differences
in 667C  T genotype frequencies among 85 mothers of
fetuses with DS and 107 controls. A similar finding was re-
ported by Petersen et al. (2001), who analyzed 177 mothers
of DS patients resulting from maternal non-disjunction in
meiosis I or II.
A possible explanation for these contradictory find-
ings is the influence of maternal age, and it may be that
MTHFR deficiency is more prevalent as a cause of non-
disjunction among younger mothers of Down syndrome
children while in older mothers maternal age may be the
risk factor. In the study by Chadefaux-Vekemans et al.
(2002) the mean age of the mothers of Down syndrome
children was 34.9 years (range: 20 to 47 years), whereas in
the study by James et al. (1999) the mean age was 29.7
years and all the mothers were less than 40 years old.
The A to C substitution at base pair 1298 of the
MTHFR gene (van der Put et al., 1998) causes a glutamate
to alanine substitution (the MTHFR 1298A  C polymor-
phism) which abolishes the MboII restriction site created
by the MTHFR 677C  T polymorphism.
Turner syndrome individuals frequently show
mosaicism (Hook and Warbuton, 1983; Robinson, 1990)
and the presence of a normal cell lineage along with the
45,X lineage is considered to increase the probability of
survival of those with 45,X Turner syndrome (Held et al.,
1992, Kelly et al., 1992).
Our study was carried out because Turner syndrome
can be used as a model for investigating the contribution of
the MTHFR gene polymorphisms to somatic chromosomal
non-disjunction and help to shed light on the role of this ge-
netic mechanism in both Down and Turner syndrome.
The study group consisted of 49 Turner syndrome in-
dividuals (mean age 15.6 ± 6.4; range 3 to 33 years) of pre-
dominantly European descent. For each individual we
assessed metaphases from a minimum of 50 and a maxi-
mum of 113 blood lymphocytes, 50 cells providing a proba-
bility of 99.9% of detecting a mosaicism in which the
minority cell line occurs with a frequency of at least 10% or
a probability of 96.2% of detecting a mosaicism including
a minority cell line with a frequency of at least 5% (Bei-
guelman, 1982). In our group 24 individuals had a 45,X
karyotype and 25 had at least one additional cell line (i.e. 22
individuals with 45,X/46,XX, one with 45,X/46,XX/
47,XXX, another with 45,X/46,XY and a third with 45,X/
46,XX/47,XX + 13). The control group was randomly se-
lected from a group of blood donors in apparently good
health and consisted of 106 females plus 94 males (n = 200
with a mean age = 27.3 ± 6.1 years; range 18 to 43 years),
110 being of predominantly European descent and 90 of
predominantly African descent. This study was approved
by the ethics committee of our institution and informed
consent was obtained from each individual or their legal
guardians.
Genomic DNA of members of the study and control
groups was extracted from lymphocytes and purified
(Woodhead et al., 1986) and the 677 region of the MTHFR
gene PCR amplified using forward (5’-TGAAGGAGAAG
GTGTCTGCGGGA-3’) and reverse (5’-AGGCGGTGC
GGTGAGAGTG-3’) primers to generate a 198-bp frag-
ment which was digested with HinfI to yield a 23 and
175 bp fragment that were separated by polyacrylamide gel
electrophoresis (Figure 1).
We also conducted PCR to amplify the 1298 region of
the MTHFR gene using forward (5’-CTTTGCGGAGCTG
AAGGACTACTAC-3’) and reverse 5’-CACTTTGTGA
CCATTCCGGTTTG-3’) primers to generate a 163-bp
fragment which was digested with MboII to yield 56, 31,
30, 28 and 18 bp fragments from the normal gene and 84,
31, 30 and 18 bp fragments from the MTHFR 1298A  C
polymorphism which were separated by polyacrylamide
gel electrophoresis (Figure 2).
In the 49 Turners syndrome individuals the frequency
of the two alleles was 677C  T = 0.39 and 1298A  C =
0.28 while that in the 200 control individuals was
677C  T = 0.29 and 1298A  C = 0.25 (Table 1). Al-
though the differences between the two groups were not
significant by the chi-squared test (2 = 5.5; for 2 degrees of
freedom (df) at p = 0.064) analysis of the adjusted residuals
using Haberman’s test suggested that the frequency of the
normal allele was somewhat decreased in the Turner syn-
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Figure 1 - Polymorphism analysis of the methylenetetrahydrofolate
reductase (MTHFR) 677C  T allele: HinfI-digested PCR fragments
from the 677C  T polymorphism (175 bp) and from the normal allele
(198 bp). M = molecular weight markers; 1 = undigested control frag-
ment; 2 = 677C  T heterozygous control: 3 and 4 = 677C  T homozy-
gous Turner syndrome (TS) individuals; 5, 8, 9, 11 and 13 = 677C  T
null TS individuals without the polymorphism; 6, 7, 10, 12 and 14 = 677C
 T heterozygous TS individuals.
drome group. When the Turner syndrome individuals were
grouped genotypically according to polymorphism a signif-
icant difference was observed for the 667C  T polymor-
phism (2 = 8.822; df = 2; p = 0.012) but not for the
12198A  C polymorphism (2 = 0.448; df = 2; p = 0.799).
Subsequent analysis of all possible genotypes using both
alleles (Table 2) revealed a significant difference between
Turner syndrome individuals and controls (2 = 12.143;
df = 5; p = 0.033), the 677C  T/677C  T homozygote
genotype being more frequent among Turner syndrome in-
dividuals as shown by an analysis of adjusted residuals us-
ing Haberman’s test. When individuals of African descent
were excluded from the control group, the differences per-
sisted (2 = 12.46; df = 5; p = 0.029).
Our results show an increase in the frequency of the
MTHFR 677C  T homozygote genotype in Turner syn-
drome individuals. Mosaicism among these patients is fre-
quent and it is believed that the presence of a normal cell
lineage along with the 45,X lineage confers viability to a
conceptus (Kelly et al, 1992). Indeed, in our study about
half of the Turner syndrome individuals tested were mosa-
ics, implying post-zygotic non-disjunction events. As men-
tioned above, the 677C  T polymorphism causes a
reduction in enzyme activity (Frosst et al., 1995) which
may lead to inhibition of methyltransferase through de-
creased levels of SAM and result in DNA hypomethylation.
Both clinical and experimental data support the importance
of pericentromeric DNA methylation for chromosomal sta-
bilization and segregation (Hobbs et al., 2000) and it ap-
pears that in homozygosis the 677C  T mutation may be a
contributing risk factor to somatic chromosomal non-
disjunction.
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